4
Changes in Ownership
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0001273351-26-000004
CHIEF ACCOUNTING OFFICER sold 43,682 shares at an average $81.49 ($3,559,495)
- CHIEF ACCOUNTING OFFICER acquired 43,682 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| CARR EDWARD CHIEF ACCOUNTING OFFICER | 2026-03-12 | Option exercise 10b5-1 | +16,182 | $17.88 | $289,334 | 16,182 | D: show line 1 in the form |
| CARR EDWARD CHIEF ACCOUNTING OFFICER | 2026-03-12 | Option exercise 10b5-1 | +17,500 | $22.07 | $386,225 | 33,682 | D: show line 2 in the form |
| CARR EDWARD CHIEF ACCOUNTING OFFICER | 2026-03-12 | Option exercise 10b5-1 | +10,000 | $21.77 | $217,700 | 43,682 | D: show line 3 in the form |
| CARR EDWARD CHIEF ACCOUNTING OFFICER | 2026-03-12 | Sale 10b5-1 | −15,852 | $80.71 | $1,279,415 | 27,830 | D: show line 4 in the form |
| CARR EDWARD CHIEF ACCOUNTING OFFICER | 2026-03-12 | Sale 10b5-1 | −23,465 | $81.75 | $1,918,264 | 4,365 | D: show line 5 in the form |
| CARR EDWARD CHIEF ACCOUNTING OFFICER | 2026-03-12 | Sale 10b5-1 | −3,865 | $82.66 | $319,481 | 500 | D: show line 6 in the form |
| CARR EDWARD CHIEF ACCOUNTING OFFICER | 2026-03-12 | Sale 10b5-1 | −200 | $83.38 | $16,676 | 300 | D: show line 7 in the form |
| CARR EDWARD CHIEF ACCOUNTING OFFICER | 2026-03-12 | Sale 10b5-1 | −300 | $85.53 | $25,659 | 0 | D: show line 8 in the form |
| Open-market sales · 43,682 sh · avg $81.49 · $3,559,495 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| CARR EDWARD CHIEF ACCOUNTING OFFICER | 2026-03-12 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −16,182 | 63,818 | D: show line 9 in the form | ||
| CARR EDWARD CHIEF ACCOUNTING OFFICER | 2026-03-12 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −17,500 | 42,500 | D: show line 10 in the form | ||
| CARR EDWARD CHIEF ACCOUNTING OFFICER | 2026-03-12 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −10,000 | 50,000 | D: show line 11 in the form |
Loading xslF345X05/ownership.xml…